ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Argen X SE

Argen X SE (ARGX)

443.70
14.70
(3.43%)
Closed July 25 11:30AM

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
443.70
Bid
440.00
Ask
450.00
Volume
155,571
435.60 Day's Range 466.40
271.00 52 Week Range 493.60
Market Cap
Previous Close
429.00
Open
440.00
Last Trade
120
@
443.7
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
63,785
Shares Outstanding
59,194,000
Dividend Yield
-
PE Ratio
-89.02
Earnings Per Share (EPS)
-4.98
Revenue
1.27B
Net Profit
-295.05M

About Argen X SE

Sector
Coml Physical, Biologcl Resh
Industry
Coml Physical, Biologcl Resh
Website
Headquarters
Amsterdam, North Holland, Nld
Founded
1970
Argen X SE is listed in the Coml Physical, Biologcl Resh sector of the Euronext with ticker ARGX. The last closing price for Argen X was 429.00 €. Over the last year, Argen X shares have traded in a share price range of 271.00 € to 493.60 €.

Argen X currently has 59,194,000 shares outstanding. The market capitalization of Argen X is 25.39 € billion. Argen X has a price to earnings ratio (PE ratio) of -89.02.

ARGX Latest News

argenx Reports Half Year 2024 Financial Results and Provides Second Quarter Business Update

$478 million in second quarter global net product sales First CIDP patients treated with VYVGART® Hytrulo following June 21st FDA approval On track to begin four additional registrational...

argenx to Report Half Year 2024 Financial Results and Second Quarter Business Update on July 25, 2024

July 18, 2024Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases...

argenx and Zai Lab Announce Approval of Efgartigimod Alfa Injection (Subcutaneous Injection) for Generalized Myasthenia Gravis in China

First and only NMPA-approved subcutaneous injectable FcRn blocker for gMG patients in China Consistent clinical benefit and safety profile of efgartigimod SC compared to IV demonstrated in...

argenx Highlights Breadth of Autoimmune Pipeline with New Multifocal Motor Neuropathy Data at 2024 Peripheral Nerve Society Annual Meeting

ARDA study data show potential for empasiprubart to drive functional improvement and reduced risk of relapse for multifocal motor neuropathy (MMN) patients ADHERE+ data show durability of...

argenx Announces FDA Approval of VYVGART Hytrulo for Chronic Inflammatory Demyelinating Polyneuropathy

VYVGART® Hytrulo is first and only neonatal Fc receptor (FcRn) blocker approved to treat chronic inflammatory demyelinating polyneuropathy (CIDP) First novel, precision mechanism of action in...

argenx to unveil its ‘Vision 2030: Taking Breakthrough Science to 50,000 Patients’ during its Upcoming R&D Day on July 16, 2024

R&D Day presentations to include recent Phase 2 datasets in Sjogren’s disease (efgartigimod) and multifocal motor neuropathy (empasiprubart) that support advancement to Phase 3 development...

argenx to Present at Goldman Sachs 45th Annual Global Healthcare Conference

June 4, 2024Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases...

argenx Reports First Quarter 2024 Financial Results and Provides Business Update

$398 million in first quarter global net product sales FDA review ongoing for CIDP sBLA with PDUFA target action date of June 21, 2024 On track to submit filing for pre-filled syringe (PFS) in...

argenx announces results of Annual General Meeting of Shareholders

May 7, 2024 – 5:30pm ET Amsterdam, the Netherlands – argenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
119.54.59688826025424.2466.4419.864559428.36172408DE
425.26.02150537634418.5466.4398.255330419.9009662DE
1286.624.2509101092357.1466.4323.463785378.80926381DE
26107.131.8181818182336.6466.4322.560941367.72920703DE
52-28.5-6.03557814485472.2493.627160433394.60281026DE
156175.865.6215005599267.9494.1224.165270347.15633939DE
260315.2245.291828794128.5494.193.0579038262.94295552DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
BFIBurgerFi International Inc
$ 0.5141
(141.25%)
12M
WINTWindtree Therapeutics Inc
$ 4.60
(39.82%)
364.99k
SPECSpectaire Holdings Inc
$ 0.5459
(36.48%)
5.45M
CLLSCellectis SA
$ 2.34
(14.15%)
327.39k
NUVOHoldco Nuvo Group DG Ltd
$ 0.80
(13.80%)
45.95k
DXCMDexCom Inc
$ 72.40
(-32.87%)
2.93M
ZYXIZynex Inc
$ 8.70
(-14.62%)
13.87k
JEWLAdamas One Corporation
$ 0.366
(-10.95%)
1.2k
NVNINVNI Group Ltd
$ 1.7065
(-9.71%)
181.96k
TNDMTandem Diabetes Care Inc
$ 37.00
(-8.98%)
76.52k
BFIBurgerFi International Inc
$ 0.5141
(141.25%)
12M
SPECSpectaire Holdings Inc
$ 0.5459
(36.48%)
5.45M
NVDANVIDIA Corporation
$ 111.56
(-0.64%)
3.86M
DXCMDexCom Inc
$ 72.40
(-32.87%)
2.93M
QDELQuidelOrtho Corporation
$ 38.24
(0.00%)
2.69M

Discussion

View Full Feed
ipiros ipiros 4 minutes ago
You are a crook along with your cronies
HIRU
CommodityCoverage CommodityCoverage 4 minutes ago
Summary of Zeus North America Mining's (ZEUS.c) Presentation at the Battery & Precious Metals Virtual Investor Conference: https://x.com/StckMasterFlash/status/1816578501300174849

Primarily focused on silver and copper, ZEUS has three properties in Idaho with its key flagship property
ZEUS
amitgupta amitgupta 4 minutes ago
Yes i did.
ViaDerma Provides Highlights of Quarterly Financial ReportThe Company is expanding its staff by hiring new full-time employees
VDRM
AtlasQ AtlasQ 4 minutes ago
I guess tomorrow could be considered the “last day” for us
RDGL
Truthfan Truthfan 4 minutes ago
“He’s not interested”

A common tactic of the basher gang is to “farm” the message board with questions and accusations designed to “harvest” information from knowledgeable posters.
NWBO
Carjockey2 Carjockey2 5 minutes ago
You're a crook and you've always been a crook nothing's changed run along...
HIRU
BigBadWolf BigBadWolf 5 minutes ago
Good to see you got the invite ;-) as well mi amigo…let’s write a song about the Ihub times :-D
The best to you & the misses.
PennyMillions852 PennyMillions852 5 minutes ago
$IGPK💩💩💩💩💩💩💩💩
IGPK
Viewmont Viewmont 5 minutes ago
Not that it's a big deal/fact. Could be new buyers approaching to close don't want those questions to remain. Who knows, we can go to hundreds of left and right name calling and conclusions. We'll find out.
HIRU
tw0122 tw0122 5 minutes ago
WINT 5.50s
WINT
Carjockey2 Carjockey2 6 minutes ago
POS EOM
HIRU
PennyMillions852 PennyMillions852 6 minutes ago
I thought we were waiting on the Chinese to start buying and this was gonna rocket???👀👀
IGPK
12yearplan 12yearplan 6 minutes ago
LOL,.. hope you don't mind if I drink - sounds like I will need it ;).
Carjockey2 Carjockey2 6 minutes ago
You got kicked off of IHub who are you kidding.

Not on ihub too much but you decided to show up today huh I don't believe in coincidences...

Funnychit
HIRU
Tomorrowneverknows Tomorrowneverknows 6 minutes ago
Yep us old school know all the players
HIRU
OneDayCloser OneDayCloser 6 minutes ago
Lol
HIRU
velcro velcro 7 minutes ago
Woodside Energy (WDS) is an Australian company listed on the NYSE.
Annual Dividend is $1.40 which is 7.8% return.
WDS might be worth an investment since they're stealing TELL.
TELL executives agreed to a reduced Bonus, but I wonder if that's the price to keep their jobs with Woo
TELL
dshade dshade 7 minutes ago
Are we spread to thin and have too many moving parts, therefore only taking baby steps across 10 different opportunities? No and only 6 opps.
Do we have enough staff to work on these opportunities? Yes
Instead, would it make sense to focus on 3? No
Move those three opportunities
ECSL
tw0122 tw0122 7 minutes ago
WINT 5.32 + 42% 400k float paying cash out some chips
WINT
Stinger2014 Stinger2014 7 minutes ago
This is the time to get back on X Mr. Rice.
CGAC

Your Recent History

Delayed Upgrade Clock